Overall, palmatine, berberine, baicalin, and geniposide have been identified as active components from HJD through their high affinity to MD-2, and their mechanisms in sepsis management were characterized by pharmacodynamics and metabolome analysis. The gene discussed is LY96; the disease is spondyloepimetaphyseal dysplasia, Handigodu type.